MedPath

Effects of music therapy as complement of chest physiotherapy in patients with cystic fibrosis

Not Applicable
Completed
Conditions
Cystic fibrosis in children with chest physiotherapy prescription
Respiratory
Cystic fibrosis with pulmonary manifestations
Registration Number
ISRCTN11161411
Lead Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/33125399/ (added 04/11/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
39
Inclusion Criteria

1. Diagnosis of cystic fibrosis based on international criteria
2. Children between ages of 2-17
3. Undergoing periodic clinic visits in the cystic fibrosis Unit
4. Understanding the purpose of the study
5. To provide written informed consent

Exclusion Criteria

1. Children without chest physiotherapy prescription
2. Children with severe hearing loss
3. Children at radiologic or clinical risk of pneumothorax or pneumomediastinum
4. Children with barotrauma in the month prior to entry in the study
5. Children with past history of massive or life-threatening haemoptysis
6. Transplant recipients or children awaiting a lung transplant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Children's and family members' enjoyment to chest physiotherapy is evaluated via questionnaire with a Likert scale (-3 to +3): least enjoyment – neutral - most enjoyment. The outcome will be measured at baseline and after 12 weeks.<br> 2. Perception of time taken to complete the routine will be evaluated via questionnaires. Perceived time values given on the questionnaire will be subtracted from actual time values given. These differences will be calculated, and then analysed. The outcome will be measured at baseline and after 12 weeks<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath